Showing results (4171-4180 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|May 22, 2024
Communicating the diagnosis of a hematological neoplastic disease to patients' minor children: a multicenter prospective studyBeatrice Manghisi, Lorenza Borin, Maria Rosaria Monaco, et al.
The Oncologist|May 22, 2024
A comprehensive analysis of POLE/POLD1 genomic alterations in colorectal cancerOsama Mosalem, Tucker W Coston, Robin Imperial, et al.
The Oncologist|May 18, 2024
Molecularly matched targeted therapy: a promising approach for refractory metastatic melanomaEmily Connell, Émilie Gerard, Bénédicte Oules, et al.
The Oncologist|May 20, 2024
Estimating scenarios for survival time in patients with advanced melanoma receiving immunotherapy and targeted therapyMegan Smith-Uffen, John Park, Andrew Parsonson, et al.
The Oncologist|June 26, 2024
Evaluation of administration-related reactions with subcutaneous daratumumab with and without premedicationKashyap Padmaraju, Kaitlin Kelly, Andrzej J Jakubowiak, et al.
The Oncologist|June 22, 2024
Tumor microenvironment characteristics association with clinical outcome in patients with resected intestinal-type gastric cancerChun-Fang Tian, Hai-Yan Jing, Frank A Sinicrope, et al.
The Oncologist|June 21, 2024
A phase 1 study of biweekly nab-paclitaxel/oxaliplatin/S-1/LV for advanced upper gastrointestinal cancers: TCOG T1216 studyHui-Jen Tsai, Shih-Hung Yang, Chin-Fu Hsiao, et al.
The Oncologist|June 17, 2024
Entinostat in patients with relapsed or refractory abdominal neuroendocrine tumorsJacob K Jamison, Mengxi Zhou, Edward P Gelmann, et al.
The Oncologist|May 23, 2024
Opioid metabolism and drug-drug interaction in cancerMatti Aapro, Stefano Fogli, Bart Morlion, et al.
The Oncologist|May 24, 2024
Unleashing patient voices: empowering adverse event assessment with complete patient-reported outcomesThi Hanh Phung, Natalie Bradford, Erin Pitt, et al.
Pageof 571